Diabetes: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
! Definition of end-point | ! Definition of end-point | ||
! Reference | ! Reference | ||
|---- | |||
| 20 yrs + <br/>4.0% in 1995 and projected to rise to 5.4% by the year 2025. | | 20 yrs + <br/>4.0% in 1995 and projected to rise to 5.4% by the year 2025. | ||
| Worldwide | | Worldwide | ||
| a venous plasma glucose concentration of 11.1 mmol/l (or its equivalent) 2 h after a 75-g oral glucose challenge. | | a venous plasma glucose concentration of 11.1 mmol/l (or its equivalent) 2 h after a 75-g oral glucose challenge. | ||
| H King, R E Aubert and W H Herman. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care September 1998 vol. 21 no. 9 1414-1431 | | H King, R E Aubert and W H Herman. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care September 1998 vol. 21 no. 9 1414-1431 | ||
|---- | |---- | ||
| All age-groups | | All age-groups <br/>estimated at 2.8% in 2000 and projected at 4.4% in 2030. | ||
| Worldwide, diabetes type 1 and 2 combined | | Worldwide, diabetes type 1 and 2 combined | ||
| a venous plasma glucose concentration of >11.1 mmol/l | | a venous plasma glucose concentration of >11.1 mmol/l <br/>2 h after a 75-g glucose tolerance test | ||
| Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, and Hilary King, Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care May 2004 vol. 27 no. 5 1047-1053. | |||
| Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, and Hilary King, | |||
|---- | |---- | ||
| 6.45% | | 6.45% | ||
| Line 32: | Line 26: | ||
| S. A. K. Stock, M. Redaelli, G. Wendland, D. Civello and K. W. Lauterbach. Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet. Med. (2005) 23(3); 299-305. | | S. A. K. Stock, M. Redaelli, G. Wendland, D. Civello and K. W. Lauterbach. Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet. Med. (2005) 23(3); 299-305. | ||
|---- | |---- | ||
| <15yrs | | <15yrs <br/>94 000 in 2005, expected to rise to 160 000 in 2020. | ||
| Europe, 1989-2003, type 1 diabetes | | Europe, 1989-2003, type 1 diabetes | ||
| | | | ||
| Dr Christopher C Patterson PhD, Prof Gisela G Dahlquist MD, Eva Gyürüs MD, Prof Anders Green MD, Prof Gyula Soltész MD. Incidence trends for childhood type 1 diabetes in Europe during 1989—2003 and predicted new cases 2005—20: a multicentre prospective registration study. The Lancet, Volume 373, Issue 9680, Pages 2027 - 2033 | | Dr Christopher C Patterson PhD, Prof Gisela G Dahlquist MD, Eva Gyürüs MD, Prof Anders Green MD, Prof Gyula Soltész MD. Incidence trends for childhood type 1 diabetes in Europe during 1989—2003 and predicted new cases 2005—20: a multicentre prospective registration study. The Lancet, Volume 373, Issue 9680, Pages 2027 - 2033 | ||
|---- | |---- | ||
| 20-79 yrs | | 20-79 yrs <br/>7.5% <br/>Rates are generally highest in countries of Central and Eastern Europe. | ||
| Europe and contains country specific information (see attached document), 2003, diagnosed and undiagnosed diabetes type 1 and 2 | | Europe and contains country specific information (see attached document), 2003, diagnosed and undiagnosed diabetes type 1 and 2 | ||
| | | | ||
| Prevalence estimates of diabetes mellitus - Diabetes Atlas, International Diabetes Federation, Generated table, Prevalence DM 2003-2025 | | Prevalence estimates of diabetes mellitus - Diabetes Atlas, International Diabetes Federation, Generated table, Prevalence DM 2003-2025 | ||
|---- | |---- | ||
| See attached document. | | See attached document. <br/>NB: WHO data greatly underestimates the true prevalence of diabetes in the population as around 50% of diabetes is undiagnosed. | ||
| EU wide and country specific (only contains countries with data), 2004-2007, diabetes prevalence % | | EU wide and country specific (only contains countries with data), 2004-2007, diabetes prevalence % | ||
| | | | ||
Revision as of 10:17, 29 June 2010
| [show] |
|---|
Scope
What is the prevalence of diabetes in the general population?
Definition
| Rate (age, sex ratio) | Context (population size studied, location, date data taken, end-point measured) | Definition of end-point | Reference |
|---|---|---|---|
| 20 yrs + 4.0% in 1995 and projected to rise to 5.4% by the year 2025. |
Worldwide | a venous plasma glucose concentration of 11.1 mmol/l (or its equivalent) 2 h after a 75-g oral glucose challenge. | H King, R E Aubert and W H Herman. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care September 1998 vol. 21 no. 9 1414-1431 |
| All age-groups estimated at 2.8% in 2000 and projected at 4.4% in 2030. |
Worldwide, diabetes type 1 and 2 combined | a venous plasma glucose concentration of >11.1 mmol/l 2 h after a 75-g glucose tolerance test |
Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, and Hilary King, Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care May 2004 vol. 27 no. 5 1047-1053. |
| 6.45% | Germany, analysis comprises data of all insured persons of six large sickness funds | ICD-9 diagnosis | S. A. K. Stock, M. Redaelli, G. Wendland, D. Civello and K. W. Lauterbach. Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet. Med. (2005) 23(3); 299-305. |
| <15yrs 94 000 in 2005, expected to rise to 160 000 in 2020. |
Europe, 1989-2003, type 1 diabetes | Dr Christopher C Patterson PhD, Prof Gisela G Dahlquist MD, Eva Gyürüs MD, Prof Anders Green MD, Prof Gyula Soltész MD. Incidence trends for childhood type 1 diabetes in Europe during 1989—2003 and predicted new cases 2005—20: a multicentre prospective registration study. The Lancet, Volume 373, Issue 9680, Pages 2027 - 2033 | |
| 20-79 yrs 7.5% Rates are generally highest in countries of Central and Eastern Europe. |
Europe and contains country specific information (see attached document), 2003, diagnosed and undiagnosed diabetes type 1 and 2 | Prevalence estimates of diabetes mellitus - Diabetes Atlas, International Diabetes Federation, Generated table, Prevalence DM 2003-2025 | |
| See attached document. NB: WHO data greatly underestimates the true prevalence of diabetes in the population as around 50% of diabetes is undiagnosed. |
EU wide and country specific (only contains countries with data), 2004-2007, diabetes prevalence % | EU Health for All Database | |
| See attached document | Country specific data, 1995 – 2002, hospital discharges due to diabetes mellitus | EUROSTAT |
Result
{{#opasnet_base_link:Op_en4519}}
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>